Stereochemical optimization of N ,2-substituted cycloalkylamines as norepinephrine reuptake inhibitors
- 12 September 2024
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 15 (12) , 4068-4079
Abstract
Optimization of previously identified N ,2-substituted cycloalkylamine scaffold for norepinephrine transport inhibition.Keywords
Funding Information
- Innovative Medicines Initiative (777372)
This publication has 50 references indexed in Scilit:
- Antidepressant binding site in a bacterial homologue of neurotransmitter transportersNature, 2007
- χ-Conotoxin and Tricyclic Antidepressant Interactions at the Norepinephrine Transporter Define a New Transporter ModelJournal of Biological Chemistry, 2007
- Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for DepressionNew England Journal of Medicine, 2006
- Lower Serotonin Transporter Binding Potential in the Human Brain During Major Depressive EpisodesAmerican Journal of Psychiatry, 2006
- SNRIs: The Pharmacology, Clinical Efficacy, and Tolerability in Comparison with Other Classes of AntidepressantsCNS Spectrums, 2005
- Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking AccuracyJournal of Medicinal Chemistry, 2004
- Stereochemistry and drug efficacy and development: relevance of chirality to antidepressant and antipsychotic drugsAnnals of Medicine, 2002
- The Protein Data BankNucleic Acids Research, 2000
- Behavioral and radioreceptor analysis of viloxazine stereoisomersBulletin of Experimental Biology and Medicine, 1984
- A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain.The Journal of Pharmacology and Experimental Therapeutics, 1982